<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Plasma antithrombin III (AT III) was studied in 39 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and in 12 patients with other <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>AT III was measured immunologically by the Mancini method as well as by functional assay using thrombin and the chromogenic substrate, chromozyn TH (Boehringer) </plain></SENT>
<SENT sid="2" pm="."><plain>Reduced AT III activity was found in 17 patients; 8 had <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In 6 patients low AT III correlated with disease exacerbations and 2 had systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>No significant correlation could be demonstrated between low AT III levels and <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>A marked variation of functional AT III activity was observed in 30 patients in whom the presence of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was demonstrated </plain></SENT>
<SENT sid="6" pm="."><plain>The significance of this association is discussed </plain></SENT>
</text></document>